Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1993 Sep;68(3):469–474. doi: 10.1038/bjc.1993.372

Haematological toxicity of carboplatin and cisplatin combined with whole body hyperthermia in rats.

S Ohno 1, F R Strebel 1, L C Stephens 1, Z H Siddik 1, H Baba 1, M Makino 1, A R Khokhar 1, J M Bull 1
PMCID: PMC1968409  PMID: 8353037

Abstract

Acute haematological toxicity induced by cis-diammine-1,1-cyclobutane dicarboxylate platinum (II) (carboplatin) and cis-diamminedichloroplatinum (II) (cisplatin) in combination with whole body hyperthermia (WBH) (2 h at 41.5 degrees C) was examined using a F344 rat model. The thermal enhancement ratios (TERs) of drug-mediated thrombocytopenia, anaemia and leukopenia were determined from the dose-response curves of the nadir values of the peripheral platelet, RBC and WBC counts. Carboplatin produced profound depression of platelet counts which was over three-fold greater than cisplatin (14% vs 51% of the control), while the decrease in WBC and RBC counts induced by carboplatin did not differ significantly from those observed with cisplatin. These carboplatin or cisplatin-mediated haematological toxicities were significantly enhanced by WBH. The depth of decrease in platelet, RBC and WBC counts induced by the maximum tolerated dose (MTD) of carboplatin (30 mg kg-1) combined with WBH was identical to that induced by the MTD of carboplatin (70 mg kg-1) alone. The TERs of carboplatin-mediated thrombocytopenia, anaemia and leukopenia were 2.0, 2.8 and 1.9, respectively. The thermal enhancement of cisplatin mediated haematological toxicity was similar to that of carboplatin, with TERs of 1.8 for thrombocytopenia, 2.4 for anaemia and 1.9 for leukopenia. These data, demonstrating thermal enhancement of cisplatin or carboplatin-mediated haematological toxicity, must be taken into account in the clinical application of the combination therapy of platinum and WBH.

Full text

PDF
469

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baba H., Siddik Z. H., Strebel F. R., Jenkins G. N., Bull J. M. Increased therapeutic gain of combined cis-diamminedichloroplatinum (II) and whole body hyperthermia therapy by optimal heat/drug scheduling. Cancer Res. 1989 Dec 15;49(24 Pt 1):7041–7044. [PubMed] [Google Scholar]
  2. Baer J., Harrison R., McAuliffe C. A., Zaki A., Sharma H. L., Smith A. G. Microscale syntheses of anti-tumour platinum compounds labelled with 191Pt. Int J Appl Radiat Isot. 1985 Mar;36(3):181–184. doi: 10.1016/0020-708x(85)90064-x. [DOI] [PubMed] [Google Scholar]
  3. Barlogie B., Corry P. M., Drewinko B. In vitro thermochemotherapy of human colon cancer cells with cis-dichlorodiammineplatinum(II) and mitomycin C. Cancer Res. 1980 Apr;40(4):1165–1168. [PubMed] [Google Scholar]
  4. Bull J. M. A review of systemic hyperthermia. Front Radiat Ther Oncol. 1984;18:171–176. doi: 10.1159/000429212. [DOI] [PubMed] [Google Scholar]
  5. Bull J. M., Strebel F. R., Sunderland B. A., Bulger R. E., Edwards M., Siddik Z. H., Newman R. A. o-(beta-Hydroxyethyl)-rutoside-mediated protection of renal injury associated with cis-diamminedichloroplatinum(II)/hyperthermia treatment. Cancer Res. 1988 Apr 15;48(8):2239–2244. [PubMed] [Google Scholar]
  6. Calvert A. H., Harland S. J., Newell D. R., Siddik Z. H., Jones A. C., McElwain T. J., Raju S., Wiltshaw E., Smith I. E., Baker J. M. Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II. Cancer Chemother Pharmacol. 1982;9(3):140–147. doi: 10.1007/BF00257742. [DOI] [PubMed] [Google Scholar]
  7. Cohen J. D., Robins H. I. Hyperthermic enhancement of cis-diammine-1,1-cyclobutane dicarboxylate platinum(II) cytotoxicity in human leukemia cells in vitro. Cancer Res. 1987 Aug 15;47(16):4335–4337. [PubMed] [Google Scholar]
  8. Gerad H., Egorin M. J., Whitacre M., Van Echo D. A., Aisner J. Renal failure and platinum pharmacokinetics in three patients treated with cis-diamminedichloroplatinum(II) and whole-body hyperthermia. Cancer Chemother Pharmacol. 1983;11(3):162–166. doi: 10.1007/BF00254197. [DOI] [PubMed] [Google Scholar]
  9. Hahn G. M. Potential for therapy of drugs and hyperthermia. Cancer Res. 1979 Jun;39(6 Pt 2):2264–2268. [PubMed] [Google Scholar]
  10. Harder H. C., Rosenberg B. Inhibitory effects of anti-tumor platinum compounds on DNA, RNA and protein syntheses in mammalian cells in virtro. Int J Cancer. 1970 Sep 15;6(2):207–216. doi: 10.1002/ijc.2910060207. [DOI] [PubMed] [Google Scholar]
  11. Mella O., Eriksen R., Dahl O., Laerum O. D. Acute systemic toxicity of combined cis-diamminedichloroplatinum and hyperthermia in the rat. Eur J Cancer Clin Oncol. 1987 Apr;23(4):365–373. doi: 10.1016/0277-5379(87)90371-3. [DOI] [PubMed] [Google Scholar]
  12. Meyn R. E., Corry P. M., Fletcher S. E., Demetriades M. Thermal enhancement of DNA damage in mammalian cells treated with cis-diamminedichloroplatinum(II). Cancer Res. 1980 Apr;40(4):1136–1139. [PubMed] [Google Scholar]
  13. Meyn R. E., Corry P. M., Fletcher S. E., Demetriades M. Thermal enhancement of DNA strand breakage in mammalian cells treated with bleomycin. Int J Radiat Oncol Biol Phys. 1979 Sep;5(9):1487–1489. doi: 10.1016/0360-3016(79)90755-7. [DOI] [PubMed] [Google Scholar]
  14. Monge O. R., Rofstad E. K. Thermochemotherapy in vivo of a C3H mouse mammary carcinoma: thermotolerant tumours. Int J Hyperthermia. 1989 Sep-Oct;5(5):579–587. doi: 10.3109/02656738909140482. [DOI] [PubMed] [Google Scholar]
  15. Nakayama T., Nakamura W. Platelet aggregation induced in mice by whole-body hyperthermia. Radiat Res. 1984 Jun;98(3):583–590. [PubMed] [Google Scholar]
  16. Ohno S., Siddik Z. H., Baba H., Stephens L. C., Strebel F. R., Wondergem J., Khokhar A. R., Bull J. M. Effect of carboplatin combined with whole body hyperthermia on normal tissue and tumor in rats. Cancer Res. 1991 Jun 1;51(11):2994–3000. [PubMed] [Google Scholar]
  17. Riviere J. E., Page R. L., Rogers R. A., Chang S. K., Dewhirst M. W., Thrall D. E. Nonuniform alteration of cis-diamminedichloroplatinum(II) tissue distribution in dogs with whole body hyperthermia. Cancer Res. 1990 Apr 1;50(7):2075–2080. [PubMed] [Google Scholar]
  18. Rose W. C., Schurig J. E., Huftalen J. B., Bradner W. T. Antitumor activity and toxicity of cisplatin analogs. Cancer Treat Rep. 1982 Jan;66(1):135–146. [PubMed] [Google Scholar]
  19. Siddik Z. H., Boxall F. E., Harrap K. R. Haematological toxicity of carboplatin in rats. Br J Cancer. 1987 Apr;55(4):375–379. doi: 10.1038/bjc.1987.75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Von Hoff D. D., Schilsky R., Reichert C. M., Reddick R. L., Rozencweig M., Young R. C., Muggia F. M. Toxic effects of cis-dichlorodiammineplatinum(II) in man. Cancer Treat Rep. 1979 Sep-Oct;63(9-10):1527–1531. [PubMed] [Google Scholar]
  21. Wagstaff A. J., Ward A., Benfield P., Heel R. C. Carboplatin. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the treatment of cancer. Drugs. 1989 Feb;37(2):162–190. doi: 10.2165/00003495-198937020-00005. [DOI] [PubMed] [Google Scholar]
  22. Wiltshaw E. Ovarian trials at the Royal Marsden. Cancer Treat Rev. 1985 Sep;12 (Suppl A):67–71. doi: 10.1016/0305-7372(85)90020-9. [DOI] [PubMed] [Google Scholar]
  23. Wondergem J., Bulger R. E., Siddik Z. H., Leygraaf J. W., Strebel F. R., Alonso M., Travis E. L., Bull J. M. A comparison of thermal enhancement of cis-diamminedichloroplatinum (II) induced renal and intestinal toxicities by whole body hyperthermia in the rat. Int J Radiat Oncol Biol Phys. 1989 Jun;16(6):1551–1556. doi: 10.1016/0360-3016(89)90961-9. [DOI] [PubMed] [Google Scholar]
  24. Wondergem J., Bulger R. E., Strebel F. R., Newman R. A., Travis E. L., Stephens L. C., Bull J. M. Effect of cis-diamminedichloroplatinum(II) combined with whole body hyperthermia on renal injury. Cancer Res. 1988 Jan 15;48(2):440–446. [PubMed] [Google Scholar]
  25. Wondergem J., Stephens L. C., Strebel F. R., Baba H., Ohno S., Siddik Z. H., Newman R. A., Bull J. M. Effect of adriamycin combined with whole body hyperthermia on tumor and normal tissues. Cancer Res. 1991 Jul 1;51(13):3559–3567. [PubMed] [Google Scholar]
  26. Wondergem J., Strebel F. R., Siddik Z. H., Newman R. A., Bull J. M. The effects of anaesthetics on cisplatinum-induced toxicity at normal temperatures and during whole-body hyperthermia: the influence of NaCl concentration of the vehicle. Int J Hyperthermia. 1988 Nov-Dec;4(6):643–654. doi: 10.3109/02656738809012403. [DOI] [PubMed] [Google Scholar]
  27. Xu M. J., Alberts D. S. Potentiation of platinum analogue cytotoxicity by hyperthermia. Cancer Chemother Pharmacol. 1988;21(3):191–196. doi: 10.1007/BF00262768. [DOI] [PubMed] [Google Scholar]
  28. Zakris E. L., Dewhirst M. W., Riviere J. E., Hoopes P. J., Page R. L., Oleson J. R. Pharmacokinetics and toxicity of intraperitoneal cisplatin combined with regional hyperthermia. J Clin Oncol. 1987 Oct;5(10):1613–1620. doi: 10.1200/JCO.1987.5.10.1613. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES